Background: The indiscriminate use of antibiotics has contributed to increase the antimicrobial resistance around the world. In some countries, like Brazil, there is no control regarding antibiotics use, once it is possible to obtain any antibiotic without medical prescription. The aim of the present study was to observe the quality of the antibiotics use (prescription, orientation and patients’
... [Show full abstract] use) in a large Brazilian city.
Methods: A survey containing 50 questions were divided into three parts: 1) questions about medical appointment and prescription; 2)about patients’ pathology; 3)about the level of information of the patient regarding antibiotics. 403 patients answered this survey right before they received the antibiotics. 3 pharmacies were included in the sample: a) commercial; b) public; c) University’s pharmacy.
Results: 28% of the samples aged from 0to10 years-old, 71% of the medical appointments were performed in the free-public healthy service and 40% of the person responsible for giving antibiotics to the children had less than four years of scholarity. 21% of all users have been using other drugs that could cause drug interactions and induce therapeutic failure (51% of patients aging 60 years or more have been using other drugs). Almost 40% of the patients did not complete the antibiotic course due to economical reasons and 20% due to disappearance of symptoms (fever). The majority of patients used water to ingest the drug, but 32% used milk. 60% of the patients did not present fever during the medical appointment (77% in patients aging > 60 years). Fifteen percent did not receive any medical orientation regarding antibiotic use. The information level of the patients regarding antibiotics was 50% of correct answers, which shows the deficiency of knowledge of the doctors and patients regarding this issue.
Conclusions: We concluded that the necessity of educational campaigns to inform the medical staff and the patients is very urgent in order to promote the rational use of antibiotics and to inhibit the bacterial resistance. Study supported by FAPESP.